Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-08-13 Sale | 2025-08-15 4:57 pm | Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director | 107,500 | $7.3159 | $786,459 | 833,483 (Direct) | View |
| 2025-06-09 Sale | 2025-06-11 4:23 pm | Axogen Inc. | AXGN | JOHNSON JOHN Director | 4,073 | $10.61 | $43,215 | 24,943 (Direct) | View |
| 2021-10-05 Sale | 2021-10-06 7:42 pm | Strongbridge Biopharma plc | SBBP | JOHNSON JOHN Chief Executive Officer | 610,092 | $0 | $0 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-19 Option Award | 2025-06-20 4:11 pm | N/A N/A | Axogen Inc. | AXGN | JOHNSON JOHN Director | 14,150 | $0 | 14,150 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-04 7:01 pm | N/A N/A | Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director | 50,000 | $0 | 940,983 (Direct) | View |
| 2025-05-22 Option Award | 2025-05-27 5:42 pm | N/A 2035-05-22 | Verastem Inc. | VSTM | JOHNSON JOHN Director | 20,833 | $0 | 29,166 (Direct) | View |
| 2024-12-19 Option Award | 2024-12-20 8:30 pm | N/A 2034-12-19 | Applied Therapeutics Inc. | APLT | JOHNSON JOHN Executive Chairman | 1,500,000 | $0 | 1,500,000 (Direct) | View |
| 2024-09-01 Exercise | 2024-09-04 9:13 pm | N/A N/A | Axogen Inc. | AXGN | JOHNSON JOHN Director | 11,904 | $0 | 29,016 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 8:27 pm | N/A 2034-06-18 | Verastem Inc. | VSTM | JOHNSON JOHN Director | 20,833 | $0 | 20,833 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-10 6:20 pm | N/A 2034-06-06 | Axogen Inc. | AXGN | JOHNSON JOHN Director | 28,901 | $0 | 35,360 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-05 4:18 pm | N/A N/A | Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director | 50,000 | $0 | 890,983 (Direct) | View |
| 2024-03-15 Other | 2024-04-01 5:43 pm | N/A N/A | Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director | 89,571 | $0 | 930,554 (Direct) | View |
| 2024-03-18 Exercise | 2024-03-18 5:32 pm | N/A 2029-11-14 | Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director | 215,600 | $0 | 751,412 (Direct) | View |
| 2024-03-18 Exercise | 2024-03-18 5:32 pm | N/A N/A | Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director | 215,600 | $1.99 | 751,412 (Direct) | View |
| 2024-03-11 Option Award | 2024-03-13 6:14 pm | N/A 2034-03-11 | Verastem Inc. | VSTM | JOHNSON JOHN Director | 8,549 | $0 | 8,549 (Direct) | View |
| 2023-09-01 Option Award | 2023-09-07 06:29 am | N/A 2033-09-01 | Axogen Inc. | AXGN | JOHNSON JOHN Director | 32,340 | $0 | 32,340 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-07 4:59 pm | N/A N/A | Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director | 42,500 | $0 | 535,812 (Direct) | View |
| 2023-06-01 Exercise | 2023-06-05 6:53 pm | N/A N/A | Axogen Inc. | AXGN | JOHNSON JOHN Director | 6,459 | $0 | 6,459 (Direct) | View |
| 2023-05-15 Option Award | 2023-05-16 4:33 pm | N/A 2033-05-15 | Verastem Inc. | VSTM | JOHNSON JOHN Director | 62,500 | $0 | 62,500 (Direct) | View |
| 2022-05-12 Option Award(A) | 2022-12-20 4:07 pm | N/A 2032-05-12 | Verastem Inc. | VSTM | JOHNSON JOHN Director | 62,500 | $0 | 62,500 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 4:11 pm | N/A 2032-06-22 | Verastem Inc. | VSTM | JOHNSON JOHN Director | 62,500 | $0 | 62,500 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-09 5:13 pm | 2022-06-08 2032-06-08 | Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director | 40,000 | $0 | 518,312 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:14 pm | N/A 2032-06-01 | Axogen Inc. | AXGN | JOHNSON JOHN Director | 18,270 | $0 | 18,270 (Direct) | View |
| 2021-10-05 Option Award(A) | 2021-10-08 6:29 pm | N/A 2025-10-16 | Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director | 866,959 | $0 | 886,609 (Direct) | View |
| 2021-10-05 Option Award(A) | 2021-10-08 6:29 pm | N/A 2031-10-05 | Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director | 19,650 | $2.37 | 886,609 (Direct) | View |
| 2021-10-05 Option Award | 2021-10-05 7:52 pm | N/A 2025-10-16 | Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director | 866,959 | $0 | 866,959 (Direct) | View |
| 2021-10-01 Tax Withholding | 2021-10-05 7:24 pm | N/A N/A | Strongbridge Biopharma plc | SBBP | JOHNSON JOHN Chief Executive Officer | 334,868 | $2.06 | 610,092 (Direct) | View |
| 2021-07-19 Option Award | 2021-07-21 4:10 pm | N/A 2031-07-19 | Axogen Inc. | AXGN | JOHNSON JOHN Director | 27,638 | $0 | 27,638 (Direct) | View |
| 2021-07-02 Tax Withholding | 2021-07-07 5:01 pm | N/A N/A | Strongbridge Biopharma plc | SBBP | JOHNSON JOHN Chief Executive Officer | 50,867 | $3.08 | 944,960 (Direct) | View |
| 2021-06-28 Option Award | 2021-06-30 2:00 pm | N/A 2031-06-28 | Verastem Inc. | VSTM | JOHNSON JOHN Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-04-08 Tax Withholding | 2021-04-09 5:13 pm | N/A N/A | Strongbridge Biopharma plc | SBBP | JOHNSON JOHN Chief Executive Officer | 17,325 | $2.68 | 995,827 (Direct) | View |
| 2021-01-07 Option Award | 2021-01-08 08:33 am | N/A N/A | Strongbridge Biopharma plc | SBBP | JOHNSON JOHN Chief Executive Officer | 491,000 | $0 | 1,013,152 (Direct) | View |